RenaissanceRe (NYSE: RNR) reported Q2 EPS of $4.06, $1.68 better than the analyst estimate of $2.38.

Second Quarter of 2020 Summary

• Gross premiums written increased by $225.0 million, or 15.2%, to $1.7 billion, in the second quarter of 2020 compared to the second quarter of 2019, driven by an increase of $203.3 million in the Property segment and an increase of $21.6 million in the Casualty and Specialty segment.
• Underwriting income of $217.1 million and a combined ratio of 78.5% in the second quarter of 2020, compared to underwriting income of $170.8 million and a combined ratio of 81.3% in the second quarter of 2019. The Property segment generated underwriting income of $200.6 million and had a combined ratio of 59.1% in the second quarter of 2020. The Casualty and Specialty segment generated underwriting income of $16.5 million and had a combined ratio of 96.8% in the second quarter of 2020.
• Total investment result was a gain of $537.7 million in the second quarter of 2020, generating an annualized total investment return of 11.8%, compared to a gain of $309.8 million and an annualized total investment return of 8.0% in the second quarter of 2019.
• On June 5, 2020, the Company issued 6,325,000 of its common shares in an underwritten public offering at a public offering price of $166.00 per share. Concurrently with the public offering, the Company raised $75.0 million through the issuance of 451,807 of its common shares at a price of $166.00 per share to State Farm Mutual Automobile Insurance Company, one of the Company’s existing stockholders, in a private placement. The total net proceeds from the offerings were $1.1 billion. The Company intends to use the net proceeds from these offerings for general corporate purposes, which may include expanding existing business lines, entering new business lines, forming new joint ventures, or acquiring books of business from other companies.
• Over $250.0 million of gross capital raised in the second quarter of 2020 through the Company’s managed joint ventures and third-party capital vehicles, including Upsilon RFO Re Ltd., Vermeer Reinsurance Ltd. (“Vermeer”) and RenaissanceRe Medici Fund Ltd (“Medici”).

Kevin J. O’Donnell, President and Chief Executive Officer of RenaissanceRe, commented: “I am proud of our team’s performance in the second quarter, where we delivered strong financial results and accomplished several strategic goals. We demonstrated market leadership in both our Property and Casualty and Specialty segments, constructing a larger and more efficient portfolio through disciplined and focused underwriting. While COVID-19 continues to present unprecedented economic and societal challenges, we feel confident with our portfolio and raised over $1 billion of new common equity in anticipation of future opportunities that we believe will deliver long-term value for our shareholders.”

For earnings history and earnings-related data on RenaissanceRe (RNR) click here.